Furthermore, preferred lung cancer metastasis sites in vivo exhibit significantly higher levels of CXCL12 protein compared with those observed at the primary tumor site or in plasma, indicating that a chemotactic gradient may be established between the site of the primary tumor and metastatic sites43. Here, CXCL12 is linked to lung cancer.